Yes this would be one way of doing it. I think we should try a range of different funding models to see which one works best. What we have learned over the last 25 years is the traditional <i>laissez faire</i> model has failed us when it comes to antibiotics.<p>One thing I should mention is we don’t have to keep developing totally new antibiotics we can develop antibiotics that are tweaks of existing antibiotics. Antibiotic resistance is an arms race that we can never win, but we can stay ahead with continued investment.